Generic Levitra (Vardenafil)

Cheap Generic Cialis, 2.11$ US Tadalafil 20mg Only.
The recommended dose of Tadalafil is 20mg.
www.cheaprxcialis.com

Order Generic Viagra 100mg x 90 pills = $ 139.95 US
Purchase generics manufactured on government certified facilities which meet or exceed the highest US Food and Drug Administration and World Health Organization standards.
www.cheaprxviagra.com

Generic Viagra Soft 100mg x 90 pills US $169.95
Generic Viagra (Sildenafil) is the most popular pills used to treat Erectile Dysfunction.
www.best0viagra.org

Buy Generic Levitra 20mg x 60 pills US $ 169.95
Now you can buy generic levitra online. Low Prices.
www.buylevitrarx.com

Medicines used to treat Parkinson’s disease may increase the risk of impulse control disorders, such as problem gambling, compulsive shopping and binge eating, researchers warn.

In a new study that included 3,090 patients being treated for Parkinson’s at 46 movement disorder centers in the United States and Canada, the researchers found that 13.6 percent of the patients had impulse control disorders. These impulse disorders included gambling (5 percent), compulsive sexual behavior (3.5 percent), compulsive shopping (5.7 percent) and binge eating (4.3 percent), and nearly 4 percent of the patients had two or more of these disorders.

Impulse control disorders were more common among patients taking dopamine agonist medications (17.1 percent) than in those not taking the drugs (6.9 percent), the study authors found. Other factors associated with impulse control disorders were: use of levodopa (another treatment for Parkinson’s); living in the United States; being younger or unmarried; smoking cigarettes; and having a family history of gambling problems.

“Dopamine agonist treatment in Parkinson’s disease is associated with 2- to 3.5-fold increased odds of having an impulse control disorder,” wrote Dr. Daniel Weintraub, of the University of Pennsylvania, Philadelphia, and Philadelphia VA Medical Center, and colleagues. “This association represents a drug class relationship across impulse control disorders. The association of other demographic and clinical variables with impulse control disorders suggests a complex relationship that requires additional investigation to optimize prevention and treatment strategies.”

The researchers noted that dopamine agonists are increasingly being used to treat other conditions, such as fibromyalgia and restless legs syndrome.

“Larger . . . studies in these other populations are needed to examine the possible relationships between dopamine agonist treatment, other clinical features and impulse control disorders,” the authors concluded.

The study is published in the May issue of the journal Archives of Neurology.

SOURCE: JAMA/Archives journals, news release.

People who’ve had a stent implanted to keep a coronary artery open face an increased risk for heart complications and death if they have non-cardiac surgery in subsequent weeks, a new Scottish study has found.

“We looked at the risks connected to four and six weeks after surgery,” said study author Nicholas L.M. Cruden, a former cardiology lecturer at the University of Edinburgh and now a consultant for the National Health Service in Scotland. “Most of the risk was in the first six weeks. Between six weeks and one year, the risk was somewhat reduced, but still higher than expected.”

The study, published online May 4 in Circulation: Cardiovascular Interventions, found that 42 percent of people undergoing non-cardiac surgery within six weeks of stent implantation were more likely to have such complications as decreased blood flow to the heart and heart attacks or to die. These outcomes were found in just 13 percent of those whose surgery was done more than six weeks after stent implantation.

The risk of heart problems after non-cardiac surgery was even greater for the 65 percent of people whose stents were inserted because of a recent heart attack, compared with those had stable but chronic heart disease when they were given stents, the study found.

There are no formal British guidelines about surgery after stent implantation, Cruden said, but in France, he said, guidelines recommend that such surgery be postponed at least for a year.

Guidelines issued by the American Heart Association and other organizations in the United States recommend delaying surgery for at least a year after a stent implant, said Dr. Charles W. Hogue Jr., associate professor of anesthesiology at Johns Hopkins University School of Medicine.

The pros and cons of using clot-preventing drugs such as Plavix after stent implants have been debated for years, Hogue said. “The guidelines set antiplatelet therapy for a year or maybe indefinitely,” he said. “If you stop, you run the risk of stenosis [artery blockage]. But what happens if you have a tendency to bleed? That can cause all kinds of problems, particularly for the brain or the eye.”

Use of clot-preventing medication has to be decided patient by patient, Hogue said. “You have to judge risk vs. benefit on an individual basis,” he said. “This is a big public health issue because a lot of stents are being implanted.”

About 1.3 million artery-opening procedures are performed annually in the United States, Hogue said.

The Scottish study is the largest done to date on the effects of surgery after stent implants, Cruden said. The study shows a 50 percent increase in the risk for bleeding in such cases but no impact on surgical mortality, he said.

SOURCES: Nicholas L. M. Cruden, Ph.D., consultant, National Health Service, Glasgow, Scotland; Charles W. Hogue Jr., M.D., associate professor, anesthesiology, Johns Hopkins University School of Medicine, Baltimore;

Poor people are more likely to die within five to 10 years after heart surgery than more affluent people, U.S. researchers report.

They followed 15,156 white men, 6,932 white women, 678 black men and 564 black women who had heart bypass or valve surgery between 1995 and 2005 and found that the poorest patients were 19 to 26 percent more likely to die within five years of surgery than the wealthiest patients, regardless of race or gender.

“We were surprised that consistently and pervasively, through every way of looking at the data, it turns out this isn’t about skin color or gender. It’s about being poor,” study author Colleen G. Koch, a cardiac anesthesiologist and vice chair for research and education in the department of cardiothoracic anesthesia at the Cleveland Clinic, said in a news release.

However, the researchers did find that poor patients were significantly more likely to be black and female.

Koch and colleagues also found that poorer patients had more atherosclerosis, serious cardiovascular disease, prior heart attacks, left ventricular dysfunction, heart failure, high blood pressure, prior stroke, peripheral artery disease, treated diabetes, and chronic obstructive pulmonary disease. They were also more likely to be smokers.

The study appears in the current issue of the journal Circulation: Cardiovascular Quality and Outcomes.

Poorer patients didn’t have a significantly higher death rate while in hospital immediately after surgery. Factors such as financial problems, educational barriers, and lack of referrals to cardiac rehabilitation programs may contribute to increased risk of death among poor patients in the years after heart surgery, Koch said.

Their survival rates might increase through improved access to primary prevention, earlier identification of risk factors, better access to long-term interventions, and enrollment in cardiac rehab programs, Koch said. Cardiac rehab typically includes monitored exercise, nutritional counseling, emotional support, and education.

Psychotherapy helps cut the incidence of psychological woes in patients with lupus who have high levels of daily stress, a new study finds.

The treatment also helps these patients improve and maintain their quality of life, according to a new Spanish study.

The research included 45 patients randomly assigned to a control group or to a therapy group. Each received 10 weekly sessions of cognitive behavioral therapy (CBT).

By the end of the study, the patients in the therapy group had significantly reduced levels of depression, anxiety and daily stress — along with significant improvement in quality of life — compared to those in the control group.

However, the patients in the therapy group didn’t show any significant reduction in lupus disease activity, said the Spanish researchers.

The study was led by N. Navarrete-Navarrete of the University Hospital Virgen de Las Nieves, and was recently published in the journal Psychotherapy and Psychosomatics.

SOURCE: Psychotherapy and Psychosomatics, news release.

Babies of women who take antidepressants during the latter part of pregnancy are slower in reaching some developmental milestones, new research shows.

Using data on more than 81,000 babies born in Denmark, researchers found that children whose mothers took antidepressants during the second or third trimester sat without support later and walked later than children of depressed mothers who did not take medication. This was especially true for boys.

Despite the delays, the children’s progress was still well within the bounds of normal development, the researchers noted. Children whose mothers took antidepressants sat about 16 days later and walked nearly a month later than the children of mothers who didn’t take the drugs.

According to the paper, researchers said they did not know if the changes were permanent or only temporary.

By 19 months, they found no differences in motor skills between kids exposed and not exposed to antidepressants.

But the 19-month-old children whose mothers had taken antidepressants were less able to occupy themselves for more than 15 minutes than toddlers whose mothers hadn’t taken antidepressants.

No other delays in any of the other 14 developmental milestones mothers were asked about, including language development, social development or other motor skills such as head control or rolling from back to belly, were noted among exposed children.

The study is published in the March issue of Pediatrics.

Despite some concerns, Dr. Diane Ashton, deputy medical director of the March of Dimes and an ob-gyn, urged women not to make any hasty decisions about discontinuing the drugs and to consult with their doctors first.

“For the most part, we feel it’s important for women to be adequately treated for depression during pregnancy,” Ashton said. “Depending on the severity of the symptoms, you may not have a choice. If the mother is depressed or suicidal to the point of hurting herself, she needs treatment.”

About 904 women in the study were depressed; of those, 415 women took antidepressants. Most took serotonin reuptake inhibitors (SSRIs), such as fluoxetine (Prozac), sertraline (Zoloft and Lustral), citalopram (Celexa) and paroxetine (Paxil). Some took an older class of drugs, tricyclic antidepressants or other types of antidepressants, including venlafaxine (Effexor). Some took more than one.

While the study isn’t the first to show that antidepressants may impact fetal development, it is among the first to look at the child’s development after birth, Ashton said.

A 2009 study in the British Medical Journal, also by the Danish researchers, found women who take certain antidepressants during the first three months of pregnancy were at a slightly increased risk of giving birth to babies with septal heart defects, or malformations in the wall separating the right side of the heart from the left. The risks were seen in sertraline and in citalopram.

Other research, however, about the risks of congenital abnormalities has been inconclusive.

So what should women do?

Discontinuing antidepressants is an option, but it has risks, especially if the mother’s depression is severe, said David Blackburn, a clinical psychologist and assistant professor of psychiatry and behavioral science at Scott & White Memorial Hospital in Temple, Texas.

Untreated depression may lead women to miss prenatal appointments, eat poorly — either too much or too little — and sleep poorly. Some people who are depressed also become socially isolated, or self-medicate with drugs or alcohol. Depression is also a risk for suicide or other self-destructive behaviors.

“Whether women continue with antidepressants has to be decided on an individual basis,” Blackburn said. “You have to weigh the risk of the depression with the slight risks of taking the antidepressants.”

In the United States, about one in five women have symptoms of depression while pregnant, according to the March of Dimes.

The U.S. Food and Drug Administration and the American College of Obstetricians and Gynecologists (ACOG) have issued warnings about an increased risk of heart defects associated with the use of the Paxil during pregnancy.

Blackburn urged women who don’t want to take medications during pregnancy not to try to go it alone and instead consider psychological counseling or support groups.

SOURCES: David Blackburn, Ph.D., M.Th., clinical psychologist, Scott & White Memorial Hospital, Temple, Texas, and assistant professor, psychiatry and behavioral science, Texas A&:M Health Science Center; Diane Ashton, M.D., M.P.H., deputy medical director, March of Dimes, White Plains, N.Y.

Chronic sleep deprivation and the impact “sleep debt” has on functioning and thinking cannot be reversed by one good night’s sleep, new research suggests.

While a night of good sleep can make you feel and operate better in the short run, the ill effects of long-term sleep loss linger much longer.

In fact, “chronic sleep loss from six hours of sleep per night for two weeks causes a similar level of impairment as staying awake for 24 hours,” said the study’s lead author, Dr. Daniel A. Cohen, a neurologist and sleep medicine specialist affiliated with Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center, both in Boston.

Chronically sleep-deprived people are “vulnerable to sudden sleepiness, errors and accidents,” Cohen added, describing the vulnerability as something that won’t disappear after a full night of “catch-up” sleep.

Cohen and his colleagues report their findings in the Jan. 13 issue of Science Translational Medicine.

They note that 16 percent of Americans are believed to routinely sleep six hours a day or less.

Such chronic sleep deprivation is thought to be most prevalent in professions that involve shift work and overtime, such as trucking and transportation, the military, the health-care industry and emergency-response organizations. Many such workers try to cope with long stretches of insufficient sleep — and the safety hazards such sleep debt poses — by sleeping for longer periods whenever they can.

But does this type of catch-up strategy help restore alertness? To find out, the researchers tracked the behavior of nine healthy men and women, 21 to 34 years old. Participants were put on a three-week sleep-wake schedule that involved staying awake for 33 hours, followed by 10 hours of sleep.

This chronic sleep deprivation routine — which they said mimicked, for example, the typical on-call schedule of a resident physician — meant that the participants slept just 5.6 hours for every 24-hour period.

Data on a second group of participants, who slept a more normal eight hours in every 24-hour period, were used as a point of comparison.

The team found that in the immediate aftermath of a 10-hour sleep period, the sleep-deprived participants did perform within normal parameters on cognitive function and reaction-time testing.

However, as the study progressed, the now chronically sleep-deprived participants’ ability to recover full function after each 10-hour sleep began to fade. Their motor skills, as well as their ability to focus, pay attention and remain alert, all weakened over the ensuring 33-hour wake period.

Relatively normal reaction times for the sleep-deprived also dissipated significantly as day turned to night. The researchers attributed this to the interplay between chronic sleep deprivation and the body’s circadian rhythms.

The bottom line: People who build up a “chronic sleep debt” during the week in the hope that they can then “pay it back” with a full night or two of sleep on the weekend are in for a disappointment.

“A long night of sleep can largely hide the effects of chronic sleep loss,” Cohen said. But he said the sense of regaining full function is illusory.

“At this point,” Cohen noted, “we still do not know how many normal sleep-wake cycles it takes to catch up on chronic sleep loss.”

Gregg D. Jacobs, a sleep specialist with the Sleep Disorders Center at University of Massachusetts Memorial Medical Center in Boston, said that “sleep loss is not a one-size-fits-all phenomenon” and cautioned against generalizing too much from the findings.

“The sleep schedule they studied is similar to what residency physicians would experience,” he noted. “However, very few people other than resident physicians ever undergo a sleep schedule like this. Sleep loss in daily life is much more modest for most people.”

Jacobs also noted that the participants were relatively young and that older adults often need less sleep. And he added that sleep loss and an individual’s related performance can often depend on how motivated a person is to execute a task, which can be different depending on whether sleep loss and performance is job-related or not.

“The problem with lab studies on sleep loss,” he stressed, is that “they do not generalize well to daily life.”

SOURCES: Daniel A. Cohen, M.D., research fellow, division of sleep medicine, Brigham and Women’s Hospital, and staff neurologist, Beth Israel Deaconess Medical Center, Boston; Gregg D. Jacobs, Ph.D., sleep specialist, Sleep Disorders Center, University of Massachusetts Memorial Medical Center, Worcester, Mass.;

New research raises the possibility that people who have the highest levels of a chemical known as BPA in their urine are more likely to be diagnosed with heart disease.

But the findings don’t prove that bisphenol A (BPA) actually causes heart disease — one scientist even suggests other factors may be at play — and researchers can’t explain why statistics suggest that urinary levels of the chemical dropped by one-third over just two years during the last decade.

Still, the numbers raise more questions about BPA, which is found in a huge variety of plastic products. “The risks associated with exposure to BPA may be small, but they are relevant to very large numbers of people,” said study author Tamara S. Galloway, a researcher at the University of Exeter in England.

BPA, which is used to make hard, clear plastic and epoxy resin, is found in everyday items, from food and drink containers to electronic and medical equipment.

It has been linked to sexual dysfunction, heart disease, cancer, diabetes and even hyperactivity in girls. But the chemical industry questions the validity of studies and contends that BPA is safe.

“Studies of this type are very limited in what they tell us about potential impacts on human health. While they can provide helpful information on where to focus future research, by themselves they cannot and should not be used to demonstrate that a particular chemical can cause a particular effect. The public should be confident that BPA is one of the most studied chemicals. Regulatory bodies from around the world have recently completed scientific evaluations and found BPA safe in food-contact products, including canned foods and beverages,” stated Steven G. Hentges, of the American Chemistry Council’s Polycarbonate/BPA Global Group.

“The study itself does not establish a cause-and-effect relationship between BPA exposure and heart disease. In addition, the robustness of these limited findings is questionable, as fewer than 50 participants self-reported health conditions without medical confirmation,” Hentges added.

Galloway and colleagues sought to confirm the results of their previous research that showed a link between BPA exposure and heart disease. They compared data regarding BPA levels in urine from 2003-2004 (in 1,455 people) to 2005-2006 (in 1,493 people), and reported their findings in the Jan. 13 edition of the online journal PLoS ONE.

The researchers don’t know why the levels dropped by one-third over just two years, although they speculate that decreased use of BPA may explain it.

After adjusting their figures to reduce the chance that they’ll be thrown off by factors such as the age, gender and race of the subjects, the researchers found that high urinary levels of BPA boosted the risk of heart disease by 1.3 to 1.4 times compared to those with low levels.

That doesn’t necessarily mean BPA makes people have heart problems. Galloway acknowledged that heart disease could somehow affect the way that the body deals with BPA and might boost its levels.

“All we can say is that the two are associated, and that the association has now been shown in two independent study populations, making it unlikely to be a chance finding,” Galloway said.

Another possible factor is the diet of those who had high BPA levels, said Dr. Hugh S. Taylor, director of Yale University School of Medicine’s division of reproductive endocrinology and infertility.

“People who eat out of cans and plastic have higher BPA levels, however they also have a lot of other reasons to have heart disease. Bad diets are clearly a cause of heart disease as well,” he said. “This study is interesting and should make people concerned; it does not prove that BPA causes heart disease.”

To find out if one thing causes another, scientists often turn to the “gold standard” in medical research: a randomized, controlled double-blind study. In this case, people would be randomly assigned to either be exposed to BPA or not, then researchers would watch to see that happened.

However, in regards to potentially harmful BPA exposure, “this would be unacceptable to any ethics committee,” Galloway said. “Also, based on the current data, it would likely be very hard to find enough people for the control group who did not have detectable levels of BPA in their urine.”

In other words, almost everyone has BPA in their system, making it harder to figure out exactly what it does, if anything, to the body.

SOURCES: Tamara Galloway, Ph.D., professor, ecotoxicology, University of Exeter, U.K.; Hugh S. Taylor, M.D., director, division of reproductive endocrinology and infertility, Yale University School of Medicine, New Haven, Conn.; Steven G. Hentges, Polycarbonate/BPA Global Group, American Chemistry Council;

educed dosages of dopamine agonists, drugs routinely used to treat Parkinson’s disease, can cause symptoms similar to those experienced by addicts in withdrawal, such as anxiety, panic attacks, pain, dizziness and drug cravings, researchers say.

The symptoms of what the researchers have dubbed “dopamine agonist withdrawal syndrome” have been linked to a disruption in levels of dopamine in the brain, according to the study published in the Jan. 12 issue of the Archives of Neurology.

“Like cocaine and methamphetamines, dopamine agonists work by stimulating the reward pathways in the brain,” senior study author Dr. Melissa J. Nirenberg, said in a news release from Weill Cornell Medical Center.

“For this reason, it makes sense that they would engender similar withdrawal symptoms, particularly in those with high cumulative drug exposure,” explained Nirenberg, associate director of the Parkinson’s Disease and Movement Disorders Institute at New York-Presbyterian Hospital/Weill Cornell Medical Center and an assistant professor of neurology and neuroscience at Weill Cornell Medical College.

Dopamine agonists are used as an alternative to the drug L-DOPA, which can cause side effects in patients with Parkinson’s, such as involuntary movements. The dopamine agonist drugs — pramipexole (Mirapex) and ropinirole (Requip) — are also approved for treatment of restless legs syndrome.

In the study, researchers looked at the medical records of 93 people with Parkinson’s disease, 26 of whom lowered their doses of the dopamine agonist drugs. Five of these patients — 19 percent — experienced dopamine agonist withdrawal syndrome. Three of the five patients couldn’t adjust to the withdrawal symptoms and had to stay on the dopamine agonists, which can cause impulse control disorders, such as compulsive behaviors related to gambling, shopping, eating or sexual activity.

SOURCE: Weill Cornell Medical Center, news release

When diet and exercise attempts haven’t worked, increasing numbers of overweight people have turned to bariatric, or weight-loss, surgery to shed pounds.

But research reported in 2009 pointed to an unintended result: One of every five people who had bariatric surgery had broken a bone within a few years.

Were the breaks a result of the surgery? Or of the weight loss that followed? Might they have been related to something going on in the body, either before or after the surgery? Or might something else altogether have been at work?

The answers remain unclear.

The finding came from an early analysis of data from a study by researchers from the Mayo Clinic, in Rochester, Minn. The study included 97 people, most middle-age and mostly women. All had had bariatric surgery — either stapling of the stomach, called gastric bypass, or stomach banding, called gastric band surgery. In the next seven years, 21 of them had 31 fractures.

The researchers compared the fracture rate for the people in the study with the rate for residents of Olmsted County, Minn., and found that people who had undergone weight-loss surgery were nearly twice as likely to have broken a bone for the first time as were those in the general population. The rate for specific sites was higher, with the risk for fracturing a foot, for instance, nearly four times higher among people who’d had bariatric surgery than in the general population.

The researchers did not determine what caused the increase in broken limbs. Their research, presented at a meeting in June of the Endocrine Society, continues and, through a Mayo Clinic spokesman, they declined further comment.

Until more findings are in, experts can only speculate about the cause and advise people who have had or plan to have bariatric surgery to pay close attention to bone health.

Dr. John Wilder Baker, director of the medical weight-loss program and co-director for the bariatric surgery program at Baptist Health in Little Rock, Ark., said that people in the study might have been deficient in vitamin D before the surgery.

Many people don’t include enough dairy products in their diet and so are lacking in vitamin D and calcium, both important for bone strength, said Baker, who is also president of the American Society for Metabolic and Bariatric Surgery and was familiar with the Mayo research.

Weight-loss surgery, he said, could bring about changes in absorption of calcium. “With gastric bypass, there could be some malabsorption of calcium,” he said.

“Before and after gastric bypass, patients are routinely told to take at least 1,200 milligrams of calcium daily, and usually 800 milligrams of D, but that may not be enough,” Baker said.

Monitoring patients closely is crucial, he said. “No matter which surgery [of several bariatric surgery options] they have had done, they need to be monitored for calcium, vitamin D levels and parathyroid hormones long term,” he said. Parathyroid hormones help increase calcium levels in the blood.

An orthopedic surgeon also familiar with the study said that it’s important to remember that the research was reported at a preliminary stage.

“I would be very careful drawing too much from one study,” said Dr. Leon Benson, a professor of orthopedic surgery at the University of Chicago, a hand surgery consultant at the Illinois Bone and Joint Institute and a spokesman for the American Academy of Orthopaedic Surgeons.

Benson said he has not noticed an increase in fracture patients with a history of bariatric surgery.

As for the mechanism, he speculated, like Baker, that the higher fracture rate could be linked to absorption issues.

Another possibility? “Maybe the patients lost enough weight [that] it changes body image and they have balance issues,” Benson said.

For now, people who’ve had bariatric surgery “should be as careful as they can to avoid preventable fractures,” he said. “That means paying close attention to their physician’s advice about their intake of calcium and vitamin D as well as their advice about exercise, which can help keep bones strong.”